Abiopharma

🔍 Singh Prahlad R. (Executive)

Company: REVVITY, INC. (RVTY)

Report Date: 2026-08-13

Detailed Transactions and Holdings:

• Sold 7,636 shares of Common Stock (Direct)
  Date: 2026-08-13 | Code: G | equity_swap_involved: false | shares_owned_after: 105,676.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 7,636 shares of Common Stock (Direct)
  Date: 2026-08-13 | Code: G | equity_swap_involved: false | shares_owned_after: 54,219.00 | transaction_form_type: 4
• Sold 59,650 shares of Common Stock (Direct)
  Date: 2026-08-13 | Code: G | equity_swap_involved: false | shares_owned_after: 46,026.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 59,650 shares of Common Stock (Direct)
  Date: 2026-08-13 | Code: G | equity_swap_involved: false | shares_owned_after: 59,650.00 | transaction_form_type: 4

Footnotes:

• F1: The securities gifted by the Reporting Person were transferred to an irrevocable trust for the sole benefit of the Reporting Person's children. The Reporting Person's spouse is the trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
• F2: The securities gifted by the Reporting Person were transferred to the Singh Marital Trust of 2026. The Reporting Person and the Reporting Person's spouse are the trustees of the trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
• REMARKS: President, Chief Executive Officer and Director